Assessing the effect of vitamin B1 and vitamin C on treatment of sever sepsis

Assessing the effect of vitamin B1 and vitamin C on attenuation of mortality due to sever sepsis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210518051339N1

Enrollment

Registered

2021-06-01

Start date

2021-06-05

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis. Other sepsis

Interventions

Intervention 1: Intervention group: Intervention group: for each patient vitamin B1 pill (600 mg) after 12 hour at each day and vitamin C ampoule (50 mg/kg) one time at each day for 96 hours. duration

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: presence of sever sepsis based on the diagnosis of expert doctor of infectious diseases the age up of 18 the patient or his accompany can give Informed consent

Exclusion criteria

Exclusion criteria: allergic reaction to vitamin B1 and vitamin C patients can exit from study with their tendency

Design outcomes

Primary

Measure	Time frame
Measure of mortality. Timepoint: 4 days after beginning of consumption of B1 and C vitamines. Method of measurement: report of doctor.	—

Secondary

Measure	Time frame
Recovery. Timepoint: 4 days after consumption of B1 and C vitamines. Method of measurement: report of doctor.;Duration of hospitalization. Timepoint: 4 days after consumption of B1 and C vitamines. Method of measurement: report of doctor.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.kiana shirani

Esfahan University of Medical Sciences

kianashirani@med.mui.ac.ir+98 31 3668 8597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026